These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23047824)

  • 21. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.
    Janssens A; Van Roy N; Poppe B; Noens L; Philippé J; Speleman F; Offner F
    Eur J Haematol; 2012 Jul; 89(1):72-80. PubMed ID: 22509718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia.
    Ouillette P; Saiya-Cork K; Seymour E; Li C; Shedden K; Malek SN
    Clin Cancer Res; 2013 Jun; 19(11):2893-904. PubMed ID: 23620403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia.
    Zenz T; Döhner H; Stilgenbauer S
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):439-53. PubMed ID: 17707832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. More extensive genetic alterations in unmutated than in hypermutated cases of chronic lymphocytic leukemia.
    Karhu R; Tobin G; Thunberg U; Vilpo L; Sundström C; Knuutila S; Rosenquist R; Vilpo J
    Genes Chromosomes Cancer; 2003 Aug; 37(4):417-20. PubMed ID: 12800154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia.
    Parker H; Rose-Zerilli MJ; Parker A; Chaplin T; Wade R; Gardiner A; Griffiths M; Collins A; Young BD; Oscier DG; Strefford JC
    Leukemia; 2011 Mar; 25(3):489-97. PubMed ID: 21151023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel recurrent gain on 20q13 in chronic lymphocytic leukemia by array CGH and gene expression profiling.
    Rodríguez AE; Robledo C; García JL; González M; Gutiérrez NC; Hernández JA; Sandoval V; García de Coca A; Recio I; Risueño A; Martín-Núñez G; García E; Fisac R; Conde J; de Las Rivas J; Hernández JM
    Ann Oncol; 2012 Aug; 23(8):2138-2146. PubMed ID: 22228453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience.
    Spunarova M; Tom N; Pavlova S; Mraz M; Brychtova Y; Doubek M; Panovska A; Skuhrova Francova H; Brzobohata A; Pospisilova S; Mayer J; Trbusek M
    Leuk Res; 2019 Jun; 81():75-81. PubMed ID: 31054420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of chromosomal anomalies detected with FISH and their clinical correlations in B-chronic lymphocytic leukemia.
    Sindelárová L; Michalová K; Zemanová Z; Ransdorfová S; Brezinová J; Peková S; Schwarz J; Karban J; Cmunt E
    Cancer Genet Cytogenet; 2005 Jul; 160(1):27-34. PubMed ID: 15949567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic features of B-cell chronic lymphocytic leukemia.
    Stilgenbauer S; Lichter P; Döhner H
    Rev Clin Exp Hematol; 2000 Mar; 4(1):48-72. PubMed ID: 11486330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia.
    Sargent R; Jones D; Abruzzo LV; Yao H; Bonderover J; Cisneros M; Wierda WG; Keating MJ; Luthra R
    J Mol Diagn; 2009 Jan; 11(1):25-34. PubMed ID: 19074592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.
    Delgado J; Salaverria I; Baumann T; Martínez-Trillos A; Lee E; Jiménez L; Navarro A; Royo C; Santacruz R; López C; Payer AR; Colado E; González M; Armengol L; Colomer D; Pinyol M; Villamor N; Aymerich M; Carrió A; Costa D; Clot G; Giné E; López-Guillermo A; Campo E; Beà S
    Haematologica; 2014 Nov; 99(11):e231-4. PubMed ID: 24997154
    [No Abstract]   [Full Text] [Related]  

  • 33. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
    Kröber A; Bloehdorn J; Hafner S; Bühler A; Seiler T; Kienle D; Winkler D; Bangerter M; Schlenk RF; Benner A; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2006 Feb; 24(6):969-75. PubMed ID: 16418492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations.
    Leuenberger M; Frigerio S; Wild PJ; Noetzli F; Korol D; Zimmermann DR; Gengler C; Probst-Hensch NM; Moch H; Tinguely M
    Mod Pathol; 2010 Feb; 23(2):177-86. PubMed ID: 19898425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterising the TP53-deleted subgroup of chronic lymphocytic leukemia: an analysis of additional cytogenetic abnormalities detected by interphase fluorescence in situ hybridisation and array-based comparative genomic hybridisation.
    Rudenko HC; Else M; Dearden C; Brito-Babapulle V; Jones C; Dexter T; Fenwick K; Mackay A; Ashworth A; Matutes E; Gonzalez D; Catovsky D; Morgan GJ
    Leuk Lymphoma; 2008 Oct; 49(10):1879-86. PubMed ID: 18949611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic alterations in chronic lymphocytic leukaemia.
    Coll-Mulet L; Gil J
    Clin Transl Oncol; 2009 Apr; 11(4):194-8. PubMed ID: 19380295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value.
    Walker BA; Leone PE; Chiecchio L; Dickens NJ; Jenner MW; Boyd KD; Johnson DC; Gonzalez D; Dagrada GP; Protheroe RK; Konn ZJ; Stockley DM; Gregory WM; Davies FE; Ross FM; Morgan GJ
    Blood; 2010 Oct; 116(15):e56-65. PubMed ID: 20616218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.
    Haferlach C; Dicker F; Schnittger S; Kern W; Haferlach T
    Leukemia; 2007 Dec; 21(12):2442-51. PubMed ID: 17805327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathogenesis of chronic lymphocytic leukemia.
    Gaidano G; Foà R; Dalla-Favera R
    J Clin Invest; 2012 Oct; 122(10):3432-8. PubMed ID: 23023714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of chromosomal abnormalities relevant to prognosis in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification.
    Stevens-Kroef M; Simons A; Gorissen H; Feuth T; Weghuis DO; Buijs A; Raymakers R; Geurts van Kessel A
    Cancer Genet Cytogenet; 2009 Dec; 195(2):97-104. PubMed ID: 19963108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.